A natural gum, damar was investigated as a novel microencapsulating material for sustained drug delivery. Microparticles were prepared by oil-in-oil emulsion solvent evaporation method. Ibuprofen and diltiazem hydrochloride were used as model drugs. Microparticles were evaluated for particle size, encapsulation efficiency and in vitro drug release kinetics. Images of the microparticles were obtained by bright field microscopy. The effect of different gum:drug ratios and solubility of drug on microparticle properties was principally investigated. Gum damar could produce discrete and spherical microparticles with both drugs. With a freely water soluble drug (diltiazem hydrochloride), gum damar produced bigger (45-50 µm) and fast drug releasing microparticles with low encapsulation efficiencies (44-57%). Contrary, with a slightly water soluble drug (ibuprofen), gum damar produced small (24-33 µm) microparticles with better drug encapsulation (85-91%) and sustained drug delivery. The increase in gum:drug ratio showed an increase in particle size, encapsulation efficiency and decrease in drug release rate in all cases. Drug release profiles of all microparticles followed zero order kinetics. In conclusion, gum damar can be used successfully to produce discrete and spherical microparticles of ibuprofen and diltiazem hydrochloride.
Microparticulate systems more often provide controlled thus has more probabilities to produce non-spherical and drug release patterns and thereby improve the drug less permeable microparticles. Additionally, the plasticizers therapeutics response and patient compliance.
or pore formers are often needed with ethyl cellulose to Microparticles can be produced for the protection of core obtain desired film features or the drug release patterns 10 material 1 , reduction of gastric irritation 2 , conversion of Cellulose acetate phthalate principally is enteric coating liquid to pseudo-solid 3 , cell microencapsulation 4 , peptide/ material. Hydrophilic HPMC cannot be used as a wall protein delivery 5 and for designing pulsatile drug forming material and is usually incorporated for the delivery systems 6 . Poly (D,L-lactide) (PLA) and poly specific purposes like mucoadhesion. Although the above (D,L-lactide-co-glycolide) (PLGA) are the commonly details scratch only the surface of information available on studied microencapsulating materials because these are the properties of some of the various wall forming biodegradable and have a broad regulatory approval 7 . But materials, it apparently suggests that a range of polymeric
India
. their high cost eventually increases the cost of formulation. Also the copolyesters of acrylic and methacrylic acid 8 (Eudragit ® RS and RL) and cellulose derivatives 9 (ethylcellulose, hydroxypropylmethylcellulose (HPMC) and cellulose acetate phthalate) are some of the most frequently investigated microencapsulating materials for therapeutic substances. However, copolyesters of acrylic and methacrylic acid carries positive charge and have propensity to react with the therapeutic substances like heparin 8 . Ethylcellulose has a dense structure and *For correspondence E-mail: dinesh622@rediffmail.com materials has certain advantages as well as the own limitations. It therefore seems prerequisite to investigate the novel polymeric materials for the encapsulation of therapeutic substances. Such investigations usually begins with the natural gums because these are readily available, cost effective, eco-friendly, capable of multitude of chemical modifications, potentially degradable and compatible due to their natural origin 11, 12 . Perhaps thus the study of natural gums has became a sought after goal of pharmaceutical scientists. However, scarce information is available pertaining to the investigation of natural gums as microencapsulating materials for therapeutic sunstances www.ijpsonline.com
Few natural gums like guar gum, gum arabic, tamarind gum, gellan gum and xanthan gum have been investigated for their applicability in designing the microparticulate system. However, these gums have been utilized for specific purpose; xanthan has been used in association with chitosan to control microsphere degradation profile 14 , gellan gum along with polyvinyl alcohol has been used to develop novel interpenetrating polymeric network microspheres 15 , guar gum has been used for colon targeting 16, 17 , gum arabic has been used for the covalent binding of primaquine in microspheres 18 , Preparation of GD microparticles: GD microparticles were prepared by oil-in-oil emulsion solvent evaporation technique 24 . In brief, GD (1 or 2 g) was dissolved in 10 ml acetone and drug powder (1 g) was added followed by magnesium stearate (9% w/w of total gum wt.). The above mixture was stirred for 10 minutes on a magnetic stirrer and poured gradually into 160 ml of liquid paraffin (viscosity -165 cps) rotating at a speed of 1100 rpm at 31±1.5° in a 250 ml glass beaker. The above dispersion was maintained at the same temperature and stirring was continued till 9 h. tamarind gum has been used with chitosan to prepare the Microparticles were collected by vacuum filtration, composite microspheres as a support for immobilization of washed two times with 12 ml of petroleum ether (60-80) ß-galactosidase 18 .
and air dried. The dried microparticles were again washed rapidly with phosphate buffer pH 7.4 to remove Gum damar (GD) is a natural gum of plant Shorea the free or loosely bound drug. The microparticles were Wiesneri (family Dipterocarpaceae). It contains about 40% air dried and stored at 0% relative humidity (RH) before alpha-resin, 22% beta resin, 23% dammarol acid and 2.5% study. The gum:drug ratios used throughout the study water 19 . It has been used as emulsifier and stabilizer for were 1:1 and 2:1. The effect of gum:drug ratio on particle the production of colour, paints, inks and aromatic size, encapsulation efficiency (%) and in vitro drug emulsions 20 . It has been used in food and cosmetic release profile of microparticles was principally industries and in the manufacture of paper, wood, investigated. varnishes, lacquers, polishes and additive for beverages 20 . It has also been used for the water-resistant Encapsulation efficiency: coating and in pharmaceutical and dental industries for its About 50 mg of microparticles were dissolved in acetone strong binding properties 21 . In India, Sal damar is widely (0.5 ml) and drug materials were extracted several times in utilized as an indigenous system of medicine 20 . These phosphate buffer pH 7.4. The samples after suitable applications of GD project its substantial binding and film dilutions were analysed by UV Spectrophotometer forming propensity and fair compatibility with the (Shimadzu UV-1601, Kyoto, Japan) at 221 and 236.4 nm physiologic environment. In view of the above along with for ibuprofen and DLTZ content respectively. the merits of drug encapsulation, an attempt has been Encapsulation efficiency was determined by the formula, made in the present study to investigate GD as a novel Encapsulation efficiency (%)= (calculated drug content)/ microencapsulating material for therapeutic substances.
(theoretical drug content)×100. With respect to the short biological half-life, ibuprofen 22 (half-life: around 2 h) and diltiazem hydrochloride Bright field microscopy and particle size: (DLTZ) 23 (half-life: 3-4 h), were selected as model drugs To examine the sphericity and the discreteness of for encapsulation in this study.
microparticles, images were taken by the automated Leica LaborLux Leitz S bright field microscope (Germany).
MATERIALS AND METHODS
Gum damar (GD) was received as a gift sample from Innovative Marketing Services, Mumbai. Ibuprofen and diltiazem hydrochloride (DLTZ) were the gift samples from M/s. H-Joules and Co. Ltd., Nagpur. Magnesium stearate was obtained from M/s. S. D. Fine Chemicals Ltd., Mumbai. Acetone and potassium dihydrogen phosphate were procured from M/s. Ranbaxy Fine Chemicals Ltd., New Delhi. Hydrochloric acid, liquid paraffin (heavy) and petroleum ether (60-80) were purchased from M/s. Central Scientific India Ltd., Nagpur. All other materials were of analytical or reagent grade and used as received.
The microparticles were examined by the optical microscopy and the mean particle diameter was determined by measuring about 100 particles using 1-mm stage micrometer. The magnification used was 1200X.
In vitro drug release study:
The USP XXV type II (paddle type) dissolution test apparatus was used to study the drug release profile of microparticles using the buffer change method. About 50 mg of microparticles were placed in a muslin cloth (mesh 400), which was tied to the paddle, rotating at a speed of 100 rpm. A hydrochloric acid buffer pH 1. used as a dissolution medium. A 900 ml of dissolution medium maintained at 37±0.5° was employed for each batch of 50 mg microparticles throughout the study. At a periodic interval, 5 ml of the sample was withdrawn and analysed at 221 nm and 236.4 nm for ibuprofen and DLTZ content, respectively.
Drug release kinetics:
To study the underlying mechanism of drug release, dissolution data was computed in the light of different kinetic equations as follows 25 , Qt= K o t--(1), In Qt= In Qo 
RESULTS AND DISCUSSION
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Numerous techniques like the multiorifice-centrifugal 26 , wurster coating 27 , emulsion congealing 28, 29 , spray drying 30, 31 , interfacial polymerization 32 , coacervation-phase separation 33 and emulsion solvent evaporation [34] [35] [36] [37] have been extensively investigated by the researchers to produce microparticulate systems. Amongst these, emulsion solvent evaporation technique seems more useful because it offers several advantages; it requires only mild The effect of gum:drug ratio and drug solubility was investigated in terms of microparticle size, encapsulation efficiency and in vitro drug release patterns.
The increase in gum:drug ratio showed an increase in microparticle size in all cases (Table 1 ). This can be explained by the fact that increase in gum concentration produces a significant increase in the viscosity of internal phase, which increases the microemulsion droplet size and eventually the microparticle size [40] [41] [42] . Also, it has been revealed that increase in polymer content of sample
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increases the frequency of collision, which may result in fusion of semiformed or visco-elastic particles producing large microparticles 36, 43 . Importantly, the solubility property of drug showed more significant effect as compared to the gum:drug ratio on particle size of GD microparticles (Table 1 and fig. 1 ). Ibuprofen was ability of GD. Variations in the stirring speed, concentration of droplet stabilizer, height of stirrer's shaft in external medium, diameter of the container (containing dispersion medium) and the volumes of internal and external phases were tried and optimized during the initial set up of the formulation. Higher ibuprofen contents in the formulation markedly plasticized GD and thus facilitated aggregation of microparticles, which was not preventable even at the higher concentrations of magnesium stearate (data not shown). Therefore gum:drug ratios of 1:1 and 2:1 were employed in the present study. K 1 Qo conditions such as ambient temperature and constant stirring [35] [36] [37] [38] . Thus, GD microparticles were produced by the emulsion solvent evaporation technique. The microparticles prepared without droplet stabilizer showed strong aggregation. Therefore, magnesium stearate in view of its droplet stabilizing potential 39 was incorporated as droplet stabilizer in all formulations. The pilot experimentation suggested; magnesium stearate at 9% w/ w of the total gum wt. was efficient in producing the discrete and free flowing GD microparticles. GD microparticles were prepared with slightly water soluble (ibuprofen) as well as freely water soluble (DLTZ) drug material to examine the actual drug release retarding content of internal phase (Table 1) , which could be due to the increase in the availability of encapsulating material. In drug loaded GD microparticles some drug may remain present onto the surface that is loosely held and may lose to external medium during microparticle formation and to solvents during washing. The amount of such uncoated drug usually decreases with an increase in gum concentration in internal phase and thus higher gum concentrations increases the encapsulation efficiency of microparticles 38, 44 . Notably, the solubility of drug material showed significant effect on the encapsulation efficiency of microparticles. The encapsulation efficiency was much higher for ibuprofen as compared to the DLTZ microparticles (Table 1 ). This may be ascribed to the hydrophobic gum, the affinity of ibuprofen perhaps was greater than water soluble DLTZ towards GD and thus completely soluble while DLTZ was insoluble in GD GD could entrap more amount of ibuprofen. Also, more solution of acetone. Due to this, ibuprofen could form solubility of DLTZ as compared to ibuprofen in external microspheres with GD, whereas, DLTZ particles since phase may be the additional reason. were not soluble acquired GD coatings to form microcapsules. Therefore, the size of ibuprofen
The solubility of drug significantly affected the in vitro microspheres was dependent perhaps on the viscosity of drug release profile of GD microparticles. GD internal phase and the solvent removal time. On the other microparticles containing ibuprofen showed much slow hand, the particle size of DLTZ microparticles was drug release profiles as compared to that of DLTZ (fig. dependent on the particle size of DLTZ in internal 2). This may be attributed to the marked difference in phase. GD however could form the spherical and the solubility of these drugs at pH 7.4. The saturation discrete microparticles with both drugs ( fig. 1) .
solubility of ibuprofen and DLTZ in pH 7.4 is 7.43±0.51 mg/ml and 593.20±3.67 mg/ml, respectively 13,23 . This All GD microparticles showed a proportional increase in suggests that DLTZ has greater solubility than ibuprofen the encapsulation efficiency (%) with an increase in gum in dissolution media. Furthermore, ibuprofen has www.ijpsonline.com propensity to plasticize the polymeric materials, thereby making their film more flexible and less permeable 45 . So, the plasticization of GD by ibuprofen also might have contributed to the slow drug release profile of GD microparticles containing ibuprofen. On the other hand, DLTZ is a freely water soluble drug; which might have facilitate DLTZ release from GD microparticles. Notably, the microparticles containing both the drugs showed slow drug release for initial 2 h, which may be due to the low solubility of GD in acidic media. The increase in GD concentrations in the formulation has shown the decrease Sakharkar and D. M. Kokare for their help in the bright field microscopy. Authors kindly acknowledge the Innovative Marketing Services, Mumbai for providing the gift sample of GD. The authors also greatly acknowledge M/s H-Joules & Co. Ltd., Nagpur for providing the gift samples of ibuprofen and DLTZ.
phase showed an increase in particle size, encapsulation microparticles. GD in microparticulate system effectively sustained the drug release rates for the longer period of time. Freely water soluble and slightly water soluble drugs exhibited fast and slow release profiles, respectively. The drug release of GD microparticles followed zero order kinetics indicating that GD can be successfully used to prepare controlled release ibuprofen and DLTZ microparticles. www.ijpsonline.com
